BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 11, 2008
 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck

Earnings on deck
Investors are expecting a 26% drop in 4Q EPS for Cephalon, due in part to slowing growth in the company's core franchises. Analysts have noted a deceleration in 2H07 prescription growth for Provigil modafinil to treat excessive sleepiness and narcolepsy, and...

Read the full 236 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >